You are not currently logged in.
Access JSTOR through your library or other institution:
Erasing the World's Slow Stain: Strategies to Beat Multidrug-Resistant Tuberculosis
Christopher Dye, Brian G. Williams, Marcos A. Espinal and Mario C. Raviglione
New Series, Vol. 295, No. 5562 (Mar. 15, 2002), pp. 2042-2046
Published by: American Association for the Advancement of Science
Stable URL: http://www.jstor.org/stable/3076272
Page Count: 5
Preview not available
Multidrug-resistant tuberculosis (MDR) is perceived as a growing hazard to human health worldwide. Judgments about the true scale of the problem, and strategies for containing it, need to come from a balanced appraisal of the epidemiological evidence. We conclude in this review that MDR is, and will probably remain, a locally severe problem; that epidemics can be prevented by fully exploiting the potential of standard short-course chemotherapy (SCC) based on cheap and safe first-line drugs; and that best-practice SCC may even reduce the incidence of MDR where it has already become endemic. On the basis of the available, imperfect data, we recommend a three-part response to the threat of MDR: widespread implementation of SCC as the cornerstone of good tuberculosis control, improved resistance testing and surveillance, and the careful introduction of second-line drugs after a sound evaluation of cost, effectiveness, and feasibility.
Science © 2002 American Association for the Advancement of Science